Quality of Malaria Case-Management in Uganda
Author Information
Author(s): Zurovac Dejan, Tibenderana James K, Nankabirwa Joan, Ssekitooleko James, Njogu Julius N, Rwakimari John B, Meek Sylvia, Talisuna Ambrose, Snow Robert W
Primary Institution: KEMRI/Wellcome Trust Research Programme
Hypothesis
How effectively are health workers implementing artemether-lumefantrine treatment guidelines for malaria in Uganda?
Conclusion
The quality of artemether-lumefantrine case-management is not yet optimal in Uganda, despite its predominant use over non-recommended therapies.
Supporting Evidence
- AL was prescribed for 60% of patients who needed treatment according to guidelines.
- 95% of patients were prescribed the correct AL dosage.
- Only 51% of patients had their weight measured during consultations.
Takeaway
This study looked at how well doctors and nurses in Uganda are treating malaria with a specific medicine. They found that while the right medicine is often used, the way it's given to patients could be much better.
Methodology
A cross-sectional survey was conducted at all government and private-not-for-profit facilities in four Ugandan districts to assess AL prescribing, dispensing, and counseling practices.
Potential Biases
Potential bias due to the presence of study teams influencing health worker behavior.
Limitations
The study may not fully represent all health facilities in Uganda due to the focus on specific districts.
Participant Demographics
The study included 232 health workers and 1,763 outpatient consultations across various health facilities.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 3.61–7.54
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website